Dr Heike Röckmann, head of the drug survivability of omalizumab in chronic urticaria (DruSO-CU) project joins Professor Marcus Maurer to discuss the global project, the difficulties which were encountered, and how the UCARE network helped overcome these challenges. The focus of this podcast is on the importance of identifying the data in this important project.
Read more news regarding urticaria
Journal Club,News
May 26, 2023Dear all, coming Thursday, the UCARE Journal Club will be held by Ceyda Çaytemel from Cam Sakura UCARE Center on: Çaytemel C, Türkoğlu Z, Ağırgöl Ş, Ustaoğlu E, Demir FT, [...]
News
May 19, 2023Dr. Marcus Maurer recently visited Seoul (South Korea) to attend the KAAACI International Congress, where he spoke at the Novartis Korea Luncheon symposium on "Advances in CSU Treatment Optimization: Yesterday, [...]
News
May 19, 2023We are happy to have gained Seoul National University Hospital in South Korea for the UCARE network. Please see some impressions of the audit below.
